Advances in genetic cell modifications are performed routinely in research laboratories, but clinical translation requires ...

According to the Company, the premixed bags were developed to reduce preparation time and the risk of preparation errors.

That’s why it’s so important to keep up with your daily skincare needs (like cleansing, exfoliating, and treating) at home so ...

More than 70% of the tasks of home infusion pharmacists for specialty infusion medications are dedicated to patient care, according to new research published in the NHIF Infusion Journal.

Halozyme made the €11-per-share offer earlier this month, valuing Evotec at around €2 billion ($2.1 billion), saying at the ...

The phase 3 MK-3475A-D77 trial tested subcutaneous and intravenous Keytruda given every six weeks in combination with ...

Merck (NYSE:MRK) marked a major milestone in its bid to introduce a new formulation for its famous cancer therapy ...

Merck plans to discuss the data with regulators as it lags rivals Roche and Bristol Myers in bringing forward a subcutaneous ...

Seeking to extend the reign of cancer king Keytruda, Merck has shown that a subcutaneous version of the anti-PD-1 therapy performs as well as the more invasive infusion formulation in a Phase III ...

TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai” ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be in the works from Korea’s Alteogen following a licensing deal worth ...